Vaccine R&D success rates and development times

This publication has 11 references indexed in Scilit:

• Immunity to diphtheria in Northern Norway and Northwestern Russia
  European Journal of Clinical Microbiology & Infectious Diseases, 1995
• Clinical Considerations in Vaccine Trials with Special Reference to Candidate HIV Vaccines
  Published by Springer Nature ,1995
• Preclinical Safety Assessment Considerations in Vaccine Development
  Published by Springer Nature ,1995
• Discussion
  Vaccine, 1995
• Biopharmaceutical R&D Success Rates and Development Times
  Nature Biotechnology, 1994
• Safety and Immunogenicity of Live Oral Cholera Vaccine Candidate CVD 110, a ctxA ctxAzot zotace Derivative of El Tor Ogawa Vibrio cholerae
  The Journal of Infectious Diseases, 1993
• Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK children
  The Lancet, 1993
• Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
  Journal of Clinical Investigation, 1992
• Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial
  The Lancet, 1990
• SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR
  The Lancet, 1988